Fieldpoint Private Securities, LLC Meridian Bioscience Inc Transaction History

Fieldpoint Private Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$23.75 - $31.69 $2,137 - $2,852	-90 Closed	0 $0
Q1 2022 Apr 07, 2022	BUY	$19.97 - $26.94 $1,797 - $2,424	90 New	90 $2,000
Q4 2021 Jan 24, 2022	SELL	$17.46 - $21.61 $960 - $1,188	-55 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$17.35 - $22.5 $780 - $1,012	-45 Reduced 45.0%	55 $1,000
Q2 2021 Aug 12, 2021	SELL	$18.01 - $28.32 $540 - $849	-30 Reduced 23.08%	100 $2,000
Q1 2021 Apr 23, 2021	BUY	$19.76 - $29.89 $2,568 - $3,885	130 New	130 $3,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.